FDA Inspection
Surgi-Care, Inc.Surgi-Care, Inc. – FDA Inspection, Feb 10, 2020
Record Details
This FDA Inspection record concerns Surgi-Care, Inc., with an inspection on February 10, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Surgi-Care, Inc.
- Inspection Date
- February 10, 2020
- Product Type
- Biologics
View Company Profile
ID · 89971e70-1d10-435a-813e-651066499318
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1120374
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Surgi-Care, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 10, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 11, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 14, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Surgi-Care, Inc.
- FDA Inspection 997637 - 2017-01-12
- FDA Inspection 920502 - 2015-03-10
- FDA Inspection 828785 - 2013-04-11
- FDA Inspection 638764 - 2009-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.